Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in the KSA.
Campus
  • Payor
Campus
  • Payor

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

Low risk of VTE Following Early Pregnancy Loss in Pregnancies Conceived by IVF

Learn more

Rethink your Nasal Polyps. Type 2 Inflammation a Nasal Polyps mystery

Learn more

Type 2 Inflammation is the underlying cause of CRSwNP in 80% of Patients.

Learn more

Lipid-lowering therapy and care gap in patients with Familial Hypercholesterolemia

Learn more

Lipid-Lowering Therapy and Achievement of Lipid Targets ESC and EAS Guidelines

Learn more

Evaluation of lipid management following ACS

Learn more

Maternal and Perinatal Outcomes of VTE

Learn more

Use of Lipid-Lowering Therapies Over 2 Years

Prescription patterns of lipidlowering therapies over time in patients with atherosclerotic cardiovascular disease

Findings from Gould study

Learn more

The European experience: Swedeheart and AIFA registries

Highlights on the most recent real-world data on the use of PCSK9 inhibitors, including those from the Swedeheart and AIFA registries.

Learn more

Open up a world beyond their Asthma symptoms

Learn more

Perceptions and Barriers on the use of PCSK9 inhibitors

Learn more

Recurrence of VTE in Patients with Recent Gestational DVT or PE

Learn more